Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Go back to Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
(NASDAQ: CODX) Delayed: 4.29 -0.41 (8.72%)
Previous Close $4.70    52 Week High
Open $4.70    52 Week Low
Day High $4.98    P/E N/A 
Day Low $3.68    EPS
Volume 436,848